Detail your involvement
2
Endo Pharmaceuticals completed the acquisition of BioSpecifics for $658m.
Service Providers
legal advisors
Morgan Lewis & Bockius
financial advisors
Centerview Partners
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
PJT Partners
pr advisors
Kekst CNC
or
Principals
target
BIOSPECIFICS TECHNOLOGIES CORP
bidder
ENDO PHARMACEUTICALS
Principals or Service Provider not listed?Add missing Service Provider or Principal
All rights reserved. Copyright © 2025 Datasite